Laboratorios Farmaceuticos ROVI Cash Flow-to-Debt Ratio
Laboratorios Farmaceuticos ROVI cash flow-to-debt ratio. Laboratorios Farmaceuticos ROVI (ROVI) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of €73.37 Million could theoretically repay 0% of its total liabilities (€289.27 Million) in one year. Check Laboratorios Farmaceuticos ROVI (ROVI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Laboratorios Farmaceuticos ROVI (2006–2024)
Cash flow-to-debt ratio of Laboratorios Farmaceuticos ROVI from 2006 to 2024. Historical debt coverage capacity for Laboratorios Farmaceuticos ROVI across 19 annual periods. Check ROVI cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Laboratorios Farmaceuticos ROVI Cash Flow-to-Debt Ratio by Year (2006–2024)
Laboratorios Farmaceuticos ROVI cash flow-to-debt ratio by year from 2006 to 2024. Year-by-year debt coverage analysis for Laboratorios Farmaceuticos ROVI. For the full cash flow conversion analysis, see Laboratorios Farmaceuticos ROVI cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | €138.28 Million | €250.48 Million | ▲ +25.0% |
| 2023 | 0.44x | €113.25 Million | €256.39 Million | ▼ -33.6% |
| 2022 | 0.66x | €237.60 Million | €357.32 Million | ▲ +16.4% |
| 2021 | 0.57x | €149.44 Million | €261.70 Million | ▲ +144.5% |
| 2020 | 0.23x | €46.88 Million | €200.74 Million | ▲ +587.5% |
| 2019 | -0.05x | €-9.04 Million | €188.82 Million | ▼ -164.7% |
| 2018 | 0.07x | €8.53 Million | €115.23 Million | ▼ -56.2% |
| 2017 | 0.17x | €18.04 Million | €106.69 Million | ▼ -61.2% |
| 2016 | 0.44x | €45.53 Million | €104.44 Million | ▲ +46.9% |
| 2015 | 0.30x | €29.39 Million | €99.06 Million | ▲ +32.7% |
| 2014 | 0.22x | €23.00 Million | €102.85 Million | ▼ -31.4% |
| 2013 | 0.33x | €29.82 Million | €91.46 Million | ▲ +59.4% |
| 2012 | 0.20x | €19.61 Million | €95.92 Million | ▲ +83.9% |
| 2011 | 0.11x | €12.68 Million | €114.09 Million | ▼ -42.9% |
| 2010 | 0.19x | €21.19 Million | €108.75 Million | ▲ +91.2% |
| 2009 | 0.10x | €9.62 Million | €94.42 Million | ▼ -42.0% |
| 2008 | 0.18x | €12.66 Million | €72.11 Million | ▲ +818.9% |
| 2007 | 0.02x | €1.15 Million | €60.23 Million | ▼ -87.6% |
| 2006 | 0.15x | €7.72 Million | €50.23 Million | — |